Diabetes and Its Complications: From Research to Clinical Practice
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Clinical Medicine, Cell, and Organism Physiology".
Deadline for manuscript submissions: 20 September 2024 | Viewed by 61
Special Issue Editors
Interests: type 2 diabetes mellitus; diabetes medications; chronic kidney disease; heart failure; hypertension; liver disease; obesity; aging
Special Issue Information
Dear Colleagues,
Diabetes is a complex and progressive disease, accompanied by numerous complications that manifest over time. The most common impact is on the eyes, nerves, heart, blood vessels, kidneys, and liver. Conventional diabetes medications have been able to prevent and delay the progression of diabetic microvascular complications by managing blood glucose levels but prove limited in addressing complications stemming from macrovascular damage.
This Special Issue focuses on the latest research and clinical evidence concerning complications such as cardiovascular diseases; including myocardial infarction and heart failure; renal complications, like diabetic nephropathy; and complications associated with chronic diabetes-related liver metabolic diseases, such as MASLD. Additionally, it delves deeply into the intricate relationship between the risks of these complications and factors such as obesity and aging.
Additionally, emerging treatment approaches for these complications, particularly novel diabetes medications like GLP-1 receptor agonists and SGLT2 inhibitors, exhibit promising effectiveness. Recent discoveries, grounded in robust evidence, signify a transformative shift in diabetes management, fostering the exploration of more holistic and efficacious strategies.
In conclusion, this Special Issue serves as a pivotal resource, providing current insights into the dynamic interplay of diabetes, its complications, and related factors. It advances our understanding of its disease mechanisms and provides clinicians with the relevant information for informed decision making in diabetes management.
Dr. Makoto Katoh
Prof. Dr. Takaaki Senbonmatsu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetes
- cardiovascular diseases
- kidney disorders
- liver diseases
- obesity
- aging
- diabetes medications
